Revolutionizing Cornea Repair

Our engineered cornea is a true alternative to donor cornea while also offering corrective vision to the almost 13 million people globally on a donor cornea tissue waiting list.

The Problem

Corneal blindness is not rare—but donor cornea is

2 million

suffer from corneal blindness each year

One in 70

patients who need cornea tissue obtain it

13 million

globally are on a donor cornea tissue waiting list

Our Solution

CorneaClear™

The gift of sight for those who once could see

The Benefits of CorneaClear™

Simple Procedure

Our device mirrors donor tissue implant process requiring minimal surgeon training.

Simple Procedure

Our device mirrors donor tissue implant process requiring minimal surgeon training.

Low Rejection

Sterile materials that are compatible with the eye.

Low Rejection

Sterile materials that are compatible with the eye.

Quality of Life

Eliminates or reduces need for anti-rejection medication, which have side effects.

Quality of Life

Eliminates or reduces need for anti-rejection medication, which have side effects.

Accessibility

Providing a shelf stable, storable product without the need for cold storage.

Accessibility

Providing a shelf stable, storable product without the need for cold storage.

About Us

Our Vision

To expand patient access to solutions that restore, repair or rebuild damaged cornea tissue

We are developing partnerships with potential technology licensees and multiple contract organizations to market the engineered cornea.

Our Team

Visionaries in Ophthalmic Technology

We bring together bioengineering and technology to revolutionize corneal transplants

Our Partners

Invest with purpose at BioLattice

By supporting our cutting-edge research in tissue engineering, you’re not just investing in a company; you’re investing in the future of healthcare. Your commitment fuels breakthroughs that have the power to redefine medical possibilities and positively impact countless lives.

Please send us a quick message if you would like an investor presentation. We will contact you to schedule a convenient time

Press

The latest from BioLattice

2929 Arch Street Philadelphia, PA 19104

2929 Arch Street Philadelphia, PA 19104

© Copyright BioLattice 2025 | All rights reserved

© Copyright BioLattice 2025 | All rights reserved